Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LivingPhoenix Regenerative Technologies Development
Chengdu, Sichuan, China
- Ownership
- Private
- Development stage
- Other
01
Overview
The company has completed safety and efficacy evaluations of its chemically synthesized triple-helix biomimetic collagen in collaboration with Beijing Hospital, Peking University Third Hospital, Shanghai Ninth People's Hospital, and The University of Tokyo, with peer-reviewed results published in Frontiers in Bioengineering and Biotechnology (April 2025, SCI Q1). The product has completed NMPA medical device master file and cosmetic ingredient filings, with injectable biomimetic collagen lyophilized fiber classified as a Class III medical device[1][4].
- Therapeutic areas
- DermatologyOther
- Modalities
- BiomaterialRecombinant protein
- Industry
- Therapeutic Medical Devices
02
Partnerships
Beijing HospitalPeking University Third HospitalShanghai Ninth People's HospitalThe University of TokyoPeking UniversityChinese Academy of SciencesShanghai Jiao Tong UniversityNaval Medical UniversityUniversity of Science and Technology of ChinaTianfu Jincheng Laboratory
Beyond the preview
Go deeper on LivingPhoenix Regenerative Technologies Development.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on LivingPhoenix Regenerative Technologies Development.